The AHA yesterday filed a declaration supporting other organizations seeking a temporary restraining order and preliminary injunction to prevent the Centers for Medicare & Medicaid Services from cutting under its Most Favored Nation Model payments for certain Medicare Part B drugs and biologicals to no more than the lowest price that drug manufacturers receive in other similar countries.

The declaration raised both procedural and substantive concerns, including the lack of proper notice for a rule of this magnitude, the harm the rule’s implementation would likely do to patients, particularly in rural areas, and the inability for providers to negotiate new agreements with drug companies in just three weeks.

Under an interim final rule issued last month, the model will become mandatory Jan. 1 for most hospitals. The Pharmaceutical Research and Manufacturers of America, Association of Community Cancer Centers and others last week filed a federal lawsuit seeking to enjoin enforcement of the rule and declare it unconstitutional and invalid.

Related News Articles

Headline
The Trump administration today announced two actions that it claims will lower prescription drug prices. The Most Favored Nation Model would cut payments to…
Headline
Specialty drugs more than doubled as a share of retail fills for the overall U.S. population between 2010 and 2017, according to a study using various sources…
Headline
A recent analysis from the Peterson Center on Healthcare and the Kaiser Family Foundation provides an incomplete picture of U.S. spending on health care while…
Blog
A recent analysis from the Peterson Center on Healthcare and the Kaiser Family Foundation, “What drives health spending in the U.S. compared to other countries…
Headline
The House Committee on Oversight and Reform this week concluded a two-day hearing examining pricing practices for some of the nation’s costliest drugs. As…
Headline
The House Committee on Oversight and Reform today launched a two-day hearing to examine pricing practices for some of the nation’s costliest drugs.…